drugset / Trial / NCT02578277

Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates

NCT02578277

Phase 1 Completed 59 enrolled ViiV Healthcare
NaSingle-groupOpen-labelOther

Summary

The purpose of the study is to study the effects of BMS-955176 on the single-dose PK parameters of probe substrates caffeine, metoprolol, montelukast, flurbiprofen, omeprazole, midazolam, digoxin, and pravastatin

Timeline

Start
2015-11-09
Primary completion
2015-12-23
Completion
2015-12-23

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-955176 Other / unclassified
Subject Caffeine Small molecule
Subject Digoxin Other / unclassified
Subject Flurbiprofen Small molecule
Subject Metoprolol Other / unclassified
Subject Midazolam Small molecule
Subject Montelukast Other / unclassified
Subject Omeprazole Other / unclassified
Subject Pravastatin Small molecule